Please login to the form below

Not currently logged in
Email:
Password:

CEO

This page shows the latest CEO news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s Corsico to be new GSK drug dev leader

Boehringer’s Corsico to be new GSK drug dev leader

The UK-headquartered firm has underperformed on R&D and commercialisation in recent years, and CEO Emma Walmsley is determined to create a more focused and productive pharma division.

Latest news

More from news
Approximately 3 fully matching, plus 1,159 partially matching documents found.

Latest Intelligence

  • Trust me, I’m from pharma Trust me, I’m from pharma

    compliance against regulation in the core areas where pharma has tripped up in the past, says Dennis O’Brien, CEO, Lucid Group.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    CEO Nick Leschly (pictured below) talks to PME’s Andrew McConaghie about the company’s ambitious plans, and why it’s filing first in Europe. ... Pharmaceutical Market Europe spoke to Bluebird’s CEO Nick Leschly shortly after it unveiled data at

  • Communication is the key to unlocking the potential of immuno-oncology Communication is the key to unlocking the potential of immuno-oncology

    patients. David Hunt, CEO of Havas Lynx Group, writes why Big Communication in the age of IO will be crucial to realising the potential of this groundbreaking new treatment modality. ... David Hunt, CEO, Havas Lynx Group. This new treatment –

  • The rise of vertical integration in the US payer landscape The rise of vertical integration in the US payer landscape

    During a CNBC interview Cigna CEO David Cordani emphasised this acquisition would “[improve] affordability and personalization for customers and clients, and [drive] more choice, great alignment with healthcare professionals, and more

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    Jodie Morrison, CEO of Tokai Pharmaceuticals and Robert K Coughlin, President and CEO of MassBio, in a recent article on GPG in STAT, summed up why it is important: ‘The global ... If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity

More from intelligence
Approximately 0 fully matching, plus 149 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 654 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 178 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics